The glucocorticoid receptor (GR) is a growing target of anti-androgen therapy resistance in mCRPC patients, given that increased GR signaling is one mechanism through which PCa cells evade AR blockades and apoptosis [158]. The gene discussed is NR3C1; the disease is posterior cortical atrophy.